References
- Japanese Ministry of Health Labour and Welfare. The guidance on the medical treatment of COVID-19 (In Japanese) (ver 8.0). 2022. https://www.mhlw.go.jp/content/000936655.pdf
- Higuchi T, Nishida T, Iwahashi H, et al. Early clinical factors predicting the development of critical disease in japanese patients with COVID-19: a single-center, retrospective, observational study. J Med Virol. 2021;93(4):2141–2148.
- Cheung KS, Hung IFN, Chan PPY, et al. Gastrointestinal manifestations of SARS-CoV-2 infection and virus load in fecal samples from a Hong Kong cohort: systematic review and meta-analysis. Gastroenterology. 2020;159(1):81–95.
- Tariq R, Saha S, Furqan F, et al. Prevalence and mortality of COVID-19 patients with gastrointestinal symptoms: a systematic review and meta-analysis. Mayo Clin Proc. 2020;95(8):1632–1648.
- Webb Hooper M, Nápoles AM, Pérez-Stable EJ. COVID-19 and racial/ethnic disparities. JAMA. 2020;323(24):2466–2467.
- Okauchi Y, Matsuno K, Nishida T, et al. Obesity, glucose intolerance, advanced age, and lymphocytopenia are independent risk factors for oxygen requirement in Japanese patients with coronavirus disease 2019 (COVID-19). Endocr J. 2021;68(7):849–856.
- Nishida T, Iwahashi H, Yamauchi K, et al. Seroprevalence of SARS-CoV-2 antibodies among 925 staff members in an urban hospital accepting COVID-19 patients in Osaka prefecture, Japan: a cross-sectional study. Medicine (Baltimore). 2021;100(25):e26433.
- Tamai M, Maekawa A, Goto N, et al. Three cases of COVID-19 patients presenting with erythema. J Dermatol. 2020;47(10):1175–1178.
- Nishida T, Suzuki N, Ono Y, et al. How to make an alternative plastic gown during the personal protective equipment shortage due to the COVID-19 pandemic. Endoscopy. 2020;52(10):E388–E389.
- Tamai M, Sakamoto R, Goto N, et al. Cutaneous manifestations of coronavirus disease 2019 patients in Japan. J Dermatol. 2022;49(9):872–878.
- World Health Oraganization. Clinical management of COVID-19: living guideline. 2022. https://www.who.int/publications/i/item/WHO-2019-nCoV-clinical-2022-1
- National Cancer Institute. Common Terminology Criteria for Adverse Events (CTCAE). 2021. https://ctep.cancer.gov/protocolDevelopment/electronic_applications/ctc.htm#ctc_40
- Tabata S, Imai K, Kawano S, et al. Clinical characteristics of COVID-19 in 104 people with SARS-CoV-2 infection on the diamond princess cruise ship: a retrospective analysis. Lancet Infect Dis. 2020;20(9):1043–1050.
- Sultan S, Altayar O, Siddique SM, et al. AGA institute rapid review of the gastrointestinal and liver manifestations of COVID-19, Meta-Analysis of international data, and recommendations for the consultative management of patients with COVID-19. Gastroenterology. 2020;159(1):320–334 e27.
- Bhayana R, Som A, Li MD, et al. Abdominal imaging findings in COVID-19: preliminary observations. Radiology. 2020;297(1):E207–E215.
- Chen W, Pan JY. Anatomical and pathological observation and analysis of SARS and COVID-19: microthrombosis is the main cause of death. Biol Proced Online. 2021;23(1):4.
- Wang D, Hu B, Hu C, et al. Clinical characteristics of 138 hospitalized patients with 2019 novel Coronavirus-Infected pneumonia in wuhan, China. JAMA. 2020;323(11):1061–1069.
- Lin L, Jiang X, Zhang Z, et al. Gastrointestinal symptoms of 95 cases with SARS-CoV-2 infection. Gut. 2020;69(6):997–1001.
- Darnell ME, Subbarao K, Feinstone SM, et al. Inactivation of the coronavirus that induces severe acute respiratory syndrome, SARS-CoV. J Virol Methods. 2004;121(1):85–91.
- Pranata R, Huang I, Lawrensia S, et al. Proton pump inhibitor on susceptibility to COVID-19 and its severity: a systematic review and meta-analysis. Pharmacol Rep. 2021;73(6):1642–1649.
- Lamers MM, Beumer J, van der Vaart J, et al. SARS-CoV-2 productively infects human gut enterocytes. Science. 2020;369(6499):50–54.
- Xiao F, Tang M, Zheng X, et al. Evidence for gastrointestinal infection of SARS-CoV-2. Gastroenterology. 2020;158(6):1831–1833 e3.
- Mohamed DZ, Ghoneim ME, Abu-Risha SE, et al. Gastrointestinal and hepatic diseases during the COVID-19 pandemic: manifestations, mechanism and management. World J Gastroenterol. 2021;27(28):4504–4535.
- Hashimoto T, Perlot T, Rehman A, et al. ACE2 links amino acid malnutrition to microbial ecology and intestinal inflammation. Nature. 2012;487(7408):477–481.